Systemic delivery of targeted nanotherapeutic reverses angiotensin II-induced abdominal aortic aneurysms in mice

• Published in: Scientific reports Vol. 11; no. 1; p. 8584
• Main Authors: Wang, Xiaoying, Parasaram, Vaideesh, Dhital, Saphala, Nosoudi, Nasim, Hasanain, Shahd, Lane, Brooks A., Lessner, Susan M., Eberth, John F., Vyavahare, Naren R.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 21.04.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 631/61/350; 631/61/490; 631/61/54; 692/4019; 692/699/75; Aneurysms; Angiotensin; Angiotensin II; Angiotensin II - pharmacology; Animals; Antibodies - immunology; Aorta; Aortic Aneurysm, Abdominal - chemically induced; Aortic Aneurysm, Abdominal - drug therapy; Aortic aneurysms; Coronary vessels; Death; Drug delivery; Drug Delivery Systems - methods; Drug therapy; Elastin; Elastin - immunology; Homeostasis; Humanities and Social Sciences; Hydrolyzable Tannins - administration & dosage; Hydrolyzable Tannins - therapeutic use; Inflammation; Injections, Intravenous; Intravenous administration; Male; Mechanical properties; Mice; Mice, Inbred C57BL; Mortality; multidisciplinary; Nanoparticles; Nanoparticles - administration & dosage; Nanoparticles - therapeutic use; Patients; Science; Science (multidisciplinary); Serum Albumin, Bovine
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-88017-w

Abdominal aortic aneurysm (AAA) disease causes dilation of the aorta, leading to aortic rupture and death if not treated early. It is the 14th leading cause of death in the U.S. and 10th leading cause of death in men over age 55, affecting thousands of patients. Despite the prevalence of AAA, no safe and efficient pharmacotherapies exist for patients. The deterioration of the elastic lamina in the aneurysmal wall is a consistent feature of AAAs, making it an ideal target for delivering drugs to the AAA site. In this research, we conjugated nanoparticles with an elastin antibody that only targets degraded elastin while sparing healthy elastin. After induction of aneurysm by 4-week infusion of angiotensin II (Ang II), two biweekly intravenous injections of pentagalloyl glucose (PGG)-loaded nanoparticles conjugated with elastin antibody delivered the drug to the aneurysm site. We show that targeted delivery of PGG could reverse the aortic dilation, ameliorate the inflammation, restore the elastic lamina, and improve the mechanical properties of the aorta at the AAA site. Therefore, simple iv therapy of PGG loaded nanoparticles can be an effective treatment option for early to middle stage aneurysms to reverse disease progression and return the aorta to normal homeostasis.